Pediatric Oncology Experimental Therapeutics Investigators’ Consortium

Early Phase Clinical Trials in Pediatric Oncology

Promoting early clinical development of promising therapies for children, adolescents, and young adults with cancer and related disorders

Pediatric Oncology Experimental Therapeutics Investigators’ Consortium

Early Phase Clinical Trials in Pediatric Oncology

Promoting early clinical development of promising therapies for children, adolescents, and young adults with cancer and related disorders

Our Mission

To promote and accelerate with equity the early clinical development of promising therapies for the treatment of children, adolescents and young adults with cancer and related disorders.

By utilizing the expertise and resources of our collaborative network, POETIC offers new possibilities and hope to patients with recurring cancer.

Meet Our Member Institutions

Our network serves a geographically diverse patient population across the United States and Canada

Our Programs

We’re focused on developing targeted treatment options that make a difference

Meet Our Member Institutions

Our network serves a geographically diverse patient population across the United States and Canada

Our Programs

We’re focused on developing targeted treatment options that make a difference

Achievements by the Numbers

As of 2025

2003

Founded in 2003

13

Network of thirteen leading academic medical centers

5

Five new clinical trials ongoing

17

Seventeen clinical trials completed

425

Four hundred twenty-five children enrolled in clinical trials

10

Ten research experts on the Translational Genomics team

2020

After being established in 2003 at Memorial Sloan Kettering, the POETIC Research Development and Management Center was transitioned to Stanford University in early 2020.

Collective Knowledge

Our unique strength stems from our member’s expertise and commitment to working together to further cancer research.

Early Access

As we continue to expand our knowledge base of the biology of pediatric cancer, we can translate what we’ve learned into new therapies.

Making Advancements

Our research is constantly progressing. Stay informed and up to date with our latest achievements.